Javier Sanchez-Gonzalez
Overview
Explore the profile of Javier Sanchez-Gonzalez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1945
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Medina-Hernandez D, Cadiz L, Mastrangelo A, Moreno-Arciniegas A, Fernandez Tocino M, Cueto Becerra A, et al.
JACC CardioOncol
. 2025 Feb;
7(2):171-184.
PMID: 39967204
Background: Anthracycline-induced cardiotoxicity (AIC) is characterized by a disruption in myocardial metabolism. Objectives: The authors used a large animal model to test sodium-glucose cotransporter inhibitor therapy to prevent AIC. Methods:...
2.
Medina-Hernandez D, Galan-Arriola C, Sanchez-Gonzalez J, Ochala J, Ibanez B
Rev Esp Cardiol (Engl Ed)
. 2025 Feb;
PMID: 39954992
No abstract available.
3.
Redondo-Rodriguez A, Ramos-Prada A, Quintanilla J, Calvo D, Sanchez-Gonzalez J, Enriquez-Vazquez D, et al.
J Am Heart Assoc
. 2024 Nov;
13(23):e038441.
PMID: 39575703
Background: Electrophysiological characterization of ventricular tachycardia (VT) isthmus sites is complex and time-consuming. We aimed at developing and validating a global mapping strategy during programmed ventricular stimulation (PVS) to reveal...
4.
Fuster V, Garcia-Alvarez A, Devesa A, Mass V, Owen R, Quesada A, et al.
J Am Coll Cardiol
. 2024 Oct;
84(15):1391-1403.
PMID: 39357937
Background: Atherosclerosis is a dynamic process. There is little evidence regarding whether quantification of atherosclerosis extent and progression, particularly in the carotid artery, in asymptomatic individuals predicts all-cause mortality. Objectives:...
5.
Tristao-Pereira C, Fuster V, Lopez-Jimenez A, Fernandez-Pena A, Semerano A, Fernandez-Nueda I, et al.
Am Heart J
. 2024 Sep;
278:195-207.
PMID: 39322173
Rationale: Cognitive decline and dementia have been reportedly linked to atherosclerosis, the main cause of cardiovascular disease. Cohort studies identifying early brain alterations associated with subclinical atherosclerosis are warranted to...
6.
Ramos-Prada A, Redondo-Rodriguez A, Roca-Luque I, Porta-Sanchez A, Ter Bekke R, Quintanilla J, et al.
Europace
. 2024 Sep;
26(10).
PMID: 39298664
Aims: There is lack of agreement on late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) imaging processing for guiding ventricular tachycardia (VT) ablation. We aim at developing and validating a systematic...
7.
Devesa A, Fuster V, Garcia-Lunar I, Oliva B, Garcia-Alvarez A, Moreno-Arciniegas A, et al.
JACC Cardiovasc Imaging
. 2024 Sep;
18(1):48-58.
PMID: 39269413
Background: In patients with ischemic heart disease, coronary microvascular dysfunction is associated with cardiovascular risk factors and poor prognosis; however, data from healthy individuals are scarce. Objectives: The purpose of...
8.
Moreno-Arciniegas A, Garcia A, Kelm M, DAmore F, Gomes Da Silva M, Sanchez-Gonzalez J, et al.
Eur J Heart Fail
. 2024 Aug;
26(10):2213-2222.
PMID: 39212445
Aims: There is a lack of therapies able to prevent anthracycline cardiotoxicity (AC). Remote ischaemic conditioning (RIC) has shown beneficial effects in preclinical models of AC. Methods: REmote iSchemic condItioning...
9.
Falcon C, Montesinos P, Vaclavu L, Kassinopoulos M, Minguillon C, Fauria K, et al.
Alzheimers Dement
. 2024 Jul;
20(8):5183-5197.
PMID: 38958557
Introduction: Cerebral blood flow (CBF) is reduced in cognitively impaired (CI) Alzheimer's disease (AD) patients. We checked the sensitivity of time-encoded arterial spin labeling (te-ASL) in measuring CBF alterations in...
10.
Garcia-Lunar I, Jorge I, Saiz J, Solanes N, Dantas A, Rodriguez-Arias J, et al.
Basic Res Cardiol
. 2024 Mar;
119(3):419-433.
PMID: 38536505
Right ventricular (RV) failure remains the strongest determinant of survival in pulmonary hypertension (PH). We aimed to identify relevant mechanisms, beyond pressure overload, associated with maladaptive RV hypertrophy in PH....